Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
Guillermo Villacampa, Pablo Tolosa, Fernando Salvador, Rodrigo Sánchez-Bayona, Lorea Villanueva, Rodrigo Dienstmann, Eva Ciruelos, Tomás Pascual
Topics & Concepts
MedicineInternal medicineHazard ratioOncologyMetastatic breast cancerTriple-negative breast cancerBreast cancerTaxaneMeta-analysisChemotherapyAdverse effectConfidence intervalCancerCancer Immunotherapy and BiomarkersAdvanced Breast Cancer TherapiesBreast Cancer Treatment Studies